Search

everythinglearnresearchcommunity

for

Search:↓

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Isotretinoin can cause rare scalp cysts and hair loss, treatable with medication.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

Older age and specific haircare practices increase the risk of traction alopecia, and education on these factors could help prevent it.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

The study aims to understand the skin and hair characteristics of mothers and their babies, and how these may affect newborns' skin health and mothers' postpartum hair loss.

Monilethrix causes fragile, patchy hair loss.

Fractional laser therapy is a promising, effective, and minimally invasive treatment for hair loss.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.

Using platelet-rich plasma injections and 5% minoxidil topically can safely and effectively treat mild-to-moderate male pattern baldness.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Lasers can trigger skin reactions, especially in darker skin, and more research is needed to improve treatments.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Steatocystoma multiplex causes recurring skin cysts and needs early recognition for better management.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Buffy coat PRP is more effective for hair growth in androgenetic alopecia than apheresis PRP.

The buffy coat method slightly outperformed apheresis in patient-reported hair improvement for treating hair loss.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Exosome therapy is the most effective for hair growth, but it's experimental and expensive.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

New regenerative therapies show promise for treating hair loss.

The supplement significantly improves hair density and appearance in people with hair loss.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

New treatment effectively reverses hair thinning in most patients with mild side effects.